Intravascular Imaging

This channel includes news and new technology innovations for intra-vascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging systems used in the cath lab. These imaging modalities help with diagnostic decisions about how to treat atheroscolosis and help guide device placement and verification of stent apposition. The technology also is used to visualize in-stent restenosis.

News

December 23, 2008 - Volcano Corp., a manufacturer of products for the diagnosis and treatment of coronary and ...

Home December 22, 2008
Home
Feature | Ellen W. Rothschild, RN, MS

There is considerable interest in being able to clearly identify vulnerable plaque (VP) and research efforts are ...

Home October 30, 2008
Home
News

October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool ...

Home October 12, 2008
Home
Technology

The FDA has approved the LipiScan Coronary Imaging System, an angiography laser scanner by InfraReDx Inc., which ...

Home September 03, 2008
Home
News

May 8, 2008 – The first human procedure using the Volcano OCT imaging catheter, which uses optical coherence ...

Home May 07, 2008
Home
Technology

InfraReDx Inc. developed the LipiScan Coronary Imaging System that is intended to characterize fatty deposits in ...

Home April 28, 2008
Home
News

April 29, 2008 - The FDA has approved the LipiScan Coronary Imaging System, an angiography laser scanner by ...

Home April 28, 2008
Home
News

January 30, 2008 - TopSpin Medical Inc. announced the first commercial installation of the Cathamaran ...

Home January 29, 2008
Home
News

January 30, 2008 - TopSpin Medical Inc. installed the Cathamaran Intravascular MRI System at ZOL Hospital in ...

Home January 29, 2008
Home
News

December 18, 2007 - Biosense Webster Inc. has introduced aid in the diagnosis and treatment of cardiac ...

Home December 17, 2007
Home
News

October 22, 2007 – IVUS integrated on GE Healthcare’s X-ray cath lab imaging system cut procedure time by up to 40 ...

Home October 24, 2007
Home
Feature | Richard Rogoski

Just how many deaths each year can be directly attributed to vulnerable plaque (VP) is still being studied. But ...

Home July 15, 2007
Home
News

April 24, 2007 — Ascent Healthcare Solutions announced today that the FDA has increased the number of times that ...

Home April 23, 2007
Home
News

Jan. 19, 2007 — Biosense Webster made two agreements public this week with healthcare competitor modality giants ...

Home January 18, 2007
Home
News

Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the ...

Home September 18, 2006
Home
Subscribe Now